ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,294.40
0.32%
Dow Jones
38,239.66
0.40%
Brent Oil
87.945
0.30%
Bitcoin
62,519.59
-0.76%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vaccitech PLC (VACC) Quote

Vaccitech PLC

Vaccitech PLC (VACC)

NASDAQ
5.00
0.00
(0.00%)
Closed April 26 4:00PM
Delayed by 15 minutes
5.00
0.00
( 0.00% )
Pre Market: 8:00PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
5.00
Bid
4.75
Ask
4.76
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
5.00
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

VACC Latest News

More News

Form 424B3 - Prospectus [Rule 424(b)(3)]

November 07 2023
Edgar (US Regulatory)

Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal Antibody

Evaluating safety and efficacy of combining AB-729, VTP-300, nucleos(t)ide analogues and nivolumab (Opdivo®) WARMINSTER, Pa., June 21, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation...

June 21 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSPICSP Inc
$ 18.46
(36.44%)
13
INHDInno Holdings Inc
$ 0.853
(35.29%)
3.14M
BBLGBone Biologics Corporation
$ 1.94
(26.80%)
76
CKPTCheckpoint Therapeutics Inc
$ 1.75
(22.38%)
47
CTCXCarmell Corporation
$ 2.55
(22.01%)
366
MRXMarex Group PLC
$ 7.60
(-60.00%)
853
CLVRClever Leaves Holdings Inc
$ 1.71
(-58.39%)
56.84k
ADXNAddex Therapeutics Ltd
$ 7.90
(-50.93%)
4.52k
ISUNiSun Inc
$ 0.1362
(-18.93%)
105.99k
NUZENuZee Inc
$ 1.36
(-16.56%)
5.63k
AKANAkanda Corporation
$ 0.1235
(19.90%)
7.67M
PEGYPineapple Energy Inc
$ 0.0705
(12.62%)
4.22M
INHDInno Holdings Inc
$ 0.8514
(35.04%)
3.14M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 8.295
(16.01%)
2.65M
TSLATesla Inc
$ 181.60
(7.91%)
2.25M

VACC Discussion

View Posts
Awl416 Awl416 7 months ago
Lol
👍️0
Awl416 Awl416 7 months ago
Wild
👍️0
DewDiligence DewDiligence 10 months ago
VACC reports_final_phase-1/2 HBV data_for VT-300 ± Opdivo:

https://www.globenewswire.com/news-release/2023/06/21/2692120/0/en/Vaccitech-to-Present-Positive-Final-Data-at-EASL-Congress-for-Phase-1b-2-HBV002-Study-in-Adults-with-Chronic-Hepatitis-B.html

See related info in #msg-171594203.
👍️0
TheFinalCD TheFinalCD 2 years ago
whats with the 19.98 HOD?

weird
👍️0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=VACC&ty=c&p=d&b=1
👍️0
TheFinalCD TheFinalCD 2 years ago
surprisingly quiet here makinEZ$

$VACC: Open for trade....... went as low as $12.80

approaching $7 fast


Now shes up to $15.30
👍️0
DewDiligence DewDiligence 2 years ago
Today's HBV webcast:

https://event.webcasts.com/starthere.jsp?ei=1523951&tp_key=b740654b72
👍️0
makinezmoney makinezmoney 3 years ago
$VACC: Open for trade....... went as low as $12.80



Now shes up to $15.30



Big one





GO $VACC
👍️0

Your Recent History

NASDAQ
VACC
Vaccitech
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved